Updated warnings of faricimab (Vabysmo) retinal vasculitis risk
Medicines Safety Update
Published
Related content
-
GLP-1 RAs and rare vision disorder
Product warnings across the glucagon-like-peptide-1 receptor agonist (GLP-1 RA) class of medicines have been updated due to the potential for these products to cause a rare, but severe, form of eye disorder. -
Ipilimumab and serous retinal detachment
Medicines Safety Update - Information for health professionals -
New safety warnings for isotretinoin (Roaccutane)
Updates further highlight potential risks of mood-related changes and sexual disorders.